This lecture is intended as a supplementary resource for clinicians and trainees to review evidence and discuss clinical cases.
Resident core / 01
Initial assessment of new inpatient fever
A 67-year-old develops a temperature of 38.6 C on hospital day 6 while receiving antibiotics for an abdominal infection. Blood pressure and oxygen requirements are unchanged. A drain and urinary catheter remain in place.
Discuss before reading on. Which findings would require immediate treatment? What would you review before changing antibiotics?
The initial assessment includes the temperature and how it was measured, blood pressure, oxygenation, mental status, perfusion, and urine output. The timing of symptoms, procedures, devices, medications, and prior cultures helps identify a source. Prolonged fever of unknown origin has a separate evaluation. [1]
Resident core / 02
The urgency depends on sepsis probability and organ dysfunction
| Clinical assessment | Timing and rationale |
|---|---|
| Possible, probable, or definite septic shock, or probable or definite sepsis without shock | The guideline recommends immediate antimicrobials, ideally within 1 hour of recognition. Resuscitation and source evaluation proceed in parallel as indicated. |
| Possible sepsis without shock | A rapid evaluation helps distinguish infectious from noninfectious causes. If concern for infection persists, the guideline suggests starting antimicrobials within 3 hours of first suspecting sepsis. |
| Low likelihood of infection and no shock | Close monitoring and reassessment may allow antimicrobials to be deferred. Fever alone is a poor basis for broadening existing therapy. |
The guideline recommends early blood cultures, ideally before antimicrobials when sampling will not delay urgent treatment. The decision to start antimicrobials rests on clinical assessment. A procalcitonin result should not delay treatment for probable sepsis or suspected septic shock. [2]
Resident core / 03
Which findings make a test useful?
Assessment of a positive blood culture · When urine testing is useful
| Finding or concern | Focused evaluation |
|---|---|
| Bacteremia or a central-line source is plausible | Blood cultures can establish bacteremia. If a catheter source is suspected, simultaneous catheter and peripheral draws with equal blood volumes and labeled collection sites allow comparison. Growth of the same organism at least 2 hours earlier from the catheter supports a catheter source. [8] |
| New cough, hypoxemia, or respiratory findings | Respiratory findings support chest imaging and testing guided by the syndrome and exposures. Chest radiography for new ICU fever is a best-practice statement in the SCCM/IDSA guideline. |
| Urinary findings or unexplained sepsis | Urine testing is most informative when the presentation supports UTI. A catheter or pyuria alone does not establish a urinary source. |
| New unexplained diarrhea | The usual group for C. difficile testing has at least 3 new unformed stools in 24 hours without another explanation. Recent laxatives can confound that assessment. |
| Abdominal pain, ileus, abnormal drainage, or recent surgery | Abdominal and wound findings, drain function, and the adequacy of source control guide the choice of imaging with the procedural team. |
For suspected acute intra-abdominal abscess in a nonpregnant adult, the 2024 IDSA panel conditionally suggests CT as initial imaging based on very low-certainty evidence. IV contrast may improve visualization of the abscess wall. Patient factors and the clinical question inform the protocol. [4]
Formed stool is generally unsuitable for routine C. difficile testing. A positive result can persist after recovery, so repeat testing does not document cure. Fulminant CDI can present with ileus and little or no diarrhea. Urgent evaluation and treatment in that setting cannot wait for the usual stool threshold. [5]
Resident core / 04
Persistent fever can reflect a new source or a noninfectious process
Definition and scope of prolonged unexplained fever
| Possibility | Question to ask at the bedside |
|---|---|
| Uncontrolled or newly acquired infection | Is a collection undrained, a device infected, or a new syndrome developing? |
| Medication reaction | How does the fever relate to a new medication? Drug fever can occur without rash or eosinophilia. |
| Thrombosis or pulmonary embolism | Are there compatible symptoms or signs that justify directed testing? |
| Postoperative inflammation or tissue injury | Does the clinical course fit the procedure and expected recovery? Postoperative timing alone cannot exclude infection. |
| Transfusion reaction or other inflammatory disease | Does the timing suggest a transfusion reaction, or are there other clues to an inflammatory disorder? |
The medication review includes non-antibiotics. Drug fever is a diagnosis of exclusion. Rash with organ injury raises concern for a serious drug reaction and warrants prompt evaluation. [1] [6]
Resident core / 05
Reassessment should produce a specific plan
Reassessing the antibiotic indication and spectrum
In the opening case, the original diagnosis, prior cultures, antibiotic activity and exposure, drain output, and latest imaging frame the reassessment. A persistent abdominal source would raise the question of inadequate drainage for the surgical or interventional radiology team. Broader antibiotic coverage cannot compensate for an undrained infected collection. [2] [4]
Deterioration or a new localizing syndrome changes the urgency or likely source. In an improving patient without new evidence of infection, persistent fever alone is a poor basis for broadening. Review of the original indication and subsequent findings can identify therapy that is no longer needed. [2]
Example handoff. "New fever without current hemodynamic or respiratory deterioration. The team is checking the abdominal source and drain. Hypotension, increasing oxygen need, or altered mentation would prompt immediate reassessment."
Resident core / Close
What changes the plan at the bedside?
Stability and immune status set the urgency. The likely source determines which tests might change treatment. A clear handoff names the current plan and findings that would prompt escalation.
Fellow discussion / Optional
What the ICU guidance covers
The 2023 SCCM/IDSA guideline covers new fever in adult ICU patients without severe immunocompromise. Its graded recommendations are weak, alongside several best-practice statements. The ward approach in this module is a clinical adaptation. [1]
When blood cultures are indicated in an adult ICU patient, the guideline advises collecting at least two sets in sequence from separate sites without waiting between draws. For a febrile ICU patient with pyuria and suspected UTI who has a urinary catheter, the guideline recommends replacing the catheter and obtaining the specimen from the new catheter. Pyuria or catheter presence alone is insufficient to establish a urinary source. [1]
The guideline weakly advises against routine antipyretics solely to lower temperature in critically ill adults. Antipyretics can be considered when the patient values relief of fever-related discomfort. [1]
An unrevealing initial evaluation gives the team a reason to revisit the history and examination. The guideline weakly suggests FDG-PET/CT in selected critically ill adults after other testing fails to identify a cause and when transport risk is acceptable. The evidence is very low quality. [1]
Discussion variation. The temperature is unchanged, but the patient now has hypotension and confusion. How does that change the urgency before the source is known? [2]
Sources and further reading
1. SCCM/IDSA. Evaluating new fever in adult patients in the ICU. 2023.
2. Surviving Sepsis Campaign. Adult guidelines. 2026.
4. IDSA. Complicated intra-abdominal infections, diagnostic evaluation. 2024.
5. SHEA/IDSA. C. difficile infection guideline, diagnostic recommendations. 2017 update.
6. Khan DA, et al. Drug allergy practice parameter update. 2022. See also Someko H, et al. Drug fever, 2023 narrative review, for the limitations of rash and eosinophilia as diagnostic clues.
7. NICE. Bacterial meningitis and meningococcal disease. 2024.
8. Mermel LA, et al. IDSA guideline for intravascular catheter-related infection. 2009. Archived guideline and update status.
The cases are fictional. Clinical application depends on the patient and local protocols.